Cargando…

GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro

We report that GRL-09510, a novel HIV-1 protease inhibitor (PI) containing a newly-generated P2-crown-tetrahydrofuranylurethane (Crwn-THF), a P2′-methoxybenzene, and a sulfonamide isostere, is highly active against laboratory and primary clinical HIV-1 isolates (EC(50): 0.0014–0.0028 μM) with minima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amano, Masayuki, Miguel Salcedo-Gómez, Pedro, Yedidi, Ravikiran S., Delino, Nicole S., Nakata, Hirotomo, Venkateswara Rao, Kalapala, Ghosh, Arun K., Mitsuya, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613016/ https://www.ncbi.nlm.nih.gov/pubmed/28947797 http://dx.doi.org/10.1038/s41598-017-12052-9

Ejemplares similares

Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s
por: Nakata, Hirotomo, et al.
Publicado: (2019)

GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants
por: Aoki, Manabu, et al.
Publicado: (2023)

Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor
por: Hu, Guodong, et al.
Publicado: (2016)

Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
por: Bulut, Haydar, et al.
Publicado: (2020)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
por: Hattori, Shin-ichiro, et al.
Publicado: (2020)

A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency
por: Aoki, Manabu, et al.
Publicado: (2017)

GrlR, a negative regulator in enteropathogenic E. coli, also represses the expression of LEE virulence genes independently of its interaction with its cognate partner GrlA
por: Lara-Ochoa, Cristina, et al.
Publicado: (2023)

Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
por: Amano, Masayuki, et al.
Publicado: (2019)

AAA-ATPases in Protein Degradation
por: Yedidi, Ravikiran S., et al.
Publicado: (2017)

In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
por: Cho, Hyunki, et al.
Publicado: (2023)

GrlJ, a Dictyostelium GABA(B)-like receptor with roles in post-aggregation development
por: Prabhu, Yogikala, et al.
Publicado: (2007)

Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity
por: Marti, Amelia, et al.
Publicado: (2006)

The putative G protein–coupled receptor GrlD mediates extracellular polyphosphate sensing in Dictyostelium discoideum
por: Suess, Patrick M., et al.
Publicado: (2019)

Structure of GrlR and the Implication of Its EDED Motif in Mediating the Regulation of Type III Secretion System in EHEC
por: Jobichen, Chacko, et al.
Publicado: (2007)

Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization
por: Friedrich, Nikolas, et al.
Publicado: (2021)

A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro
por: Matsuda, Kouki, et al.
Publicado: (2021)

An Autocrine Proliferation Repressor Regulates Dictyostelium discoideum Proliferation and Chemorepulsion Using the G Protein-Coupled Receptor GrlH
por: Tang, Yu, et al.
Publicado: (2018)

Screening of Anti-Adhesion Agents for Pathogenic Escherichia coli O157:H7 by Targeting the GrlA Activator
por: Hong, Sin Young, et al.
Publicado: (2023)

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
por: Fu, Ziyang, et al.
Publicado: (2021)

Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands
por: Anitha, Anju Krishnan, et al.
Publicado: (2022)

A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1
por: Chan, Kun-Wei, et al.
Publicado: (2021)

Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
por: Aoki, Manabu, et al.
Publicado: (2018)

Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages
por: Dupont, Maeva, et al.
Publicado: (2020)

Recent HIV-1 Infection: Identification of Individuals with High Viral Load Setpoint in a Voluntary Counselling and Testing Centre in Rural Mozambique
por: Serna-Bolea, Celia, et al.
Publicado: (2012)

S101: COMBINATION OF A LUSPATERCEPT-LIKE DRUG (RAP-GRL) AND TMPRSS6-ASO IS SUPERIOR TO EITHER DRUG ALONE FOR CORRECTING β-THALASSEMIA
por: Guerra, A., et al.
Publicado: (2022)

Favorable outcome of pregnancy on antiretroviral treatment in a patient with HIV-infection
por: Marincu, Iosif, et al.
Publicado: (2014)

P08-01. Heme oxygenase-1 promoter polymorphisms correlate with favorable virologic and immunological parameters in HIV-1 infection
por: Seu, L, et al.
Publicado: (2009)

HIV-1 protease-induced apoptosis
por: Rumlová, Michaela, et al.
Publicado: (2014)

Granule lattice protein 1 (Grl1p), an acidic, calcium-binding protein in Tetrahymena thermophila dense-core secretory granules, influences granule size, shape, content organization, and release but not protein sorting or condensation
Publicado: (1996)

P04-42. Molecular design of a mimotope that preserves conserved structural elements of the HIV-1 V3 crown
por: Jiang, X, et al.
Publicado: (2009)

Whiskers-less HIV-protease: a possible way for HIV-1 deactivation
por: Dayer, Mohammad Reza, et al.
Publicado: (2013)

The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation
por: Nicoli, Francesco, et al.
Publicado: (2020)

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
por: Petkov, Stefan, et al.
Publicado: (2022)

HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes
por: Cilento, Maria E., et al.
Publicado: (2023)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

The evolution of the HIV-1 protease folding stability
por: Ferreiro, David, et al.
Publicado: (2022)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
por: Fun, Axel, et al.
Publicado: (2011)

Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus
por: Rizvi, Saliha, et al.
Publicado: (2016)

Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow
por: Parmar, Paritosh, et al.
Publicado: (2021)

Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7s17flkcdmhrnhof40ub423uo6